Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma

Bone Marrow Transplant. 2018 Mar;53(3):366-370. doi: 10.1038/s41409-017-0032-1. Epub 2017 Dec 21.

Jacopo Mariotti¹, Stefania Bramanti², Raynier Devillier³, Sabine Furst³, Jean El Cheikh³, Barbara Sarina², Angela Granata³, Catherine Faucher³, Samia Harbi³, Lucio Morabito², Pierre Jean Weiller³, Christian Chabannon^{4

5

6}, Jamel Mokart⁷, Rossana Mineri⁸, Carmelo Carlo-Stella^{2

9}, Armando Santoro^{2

10}, Didier Blaise^{3

5

6}, Luca Castagna²

¹ Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy. [email protected].
² Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano, Italy.
³ Department of Hematology, Transplantation Program, Marseille, France.
⁴ Cell Therapy Unit, Institut Paoli Calmettes, Marseille, France.
⁵ Aix-Marseille Université, Marseille, France.
⁶ Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
⁷ Intensive Care Unit, Institut Paoli Calmettes, Marseille, France.
⁸ Molecular Biology Section, Clinical Investigation Laboratory, Humanitas Cancer Center, Milan, Italy.
⁹ Department of Medical Biotechnology and Translational Medicine, University of Milano, Milano, Italy.
¹⁰ Humanitas University, Humanitas Clinical and Research Hospital, Rozzano, Italy.

No abstract available

Publication types